A Phase I Trial of Anti-CC Chemokine Receptor 4 Chimeric Antigen Receptor T Cells (CCR4 CAR T Cells) for CCR4 Expressing T-cell Malignancies Including Peripheral T-cell Non-Hodgkin Lymphoma (PTCL) and Cutaneous T-cell Non-Hodgkin Lymphoma (CTCL)

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source

ClinicalTrials.gov

Source record ID

NCT07055477

Title field or adapter rule

protocolSection.identificationModule.officialTitle

Ingested At

2026-04-25T22:28:23.311739+00:00

Published At

2026-02-20T00:00:00+00:00

Record Updated At

2026-02-20

Timestamp Basis

source retrieval time was not retained by the feed adapter

Date limitation

source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions

["Relapsed and/or Refractory Mature T Cell Malignancy", "Peripheral T-Cell Lymphoma", "Angioimmunoblastic T-cell Lymphoma", "Anaplastic Large Cell Lymphoma", "Hepatosplenic T-cell Lymphoma", "Monomorphic Epithelialtropic Intestinal Lymphoma", "Enteropathy Associated T-cell Lymphoma", "Cutaneous T-Cell Lymphoma", "Mycosis Fungoides", "Subacute Panniculitis-like T-cell Lymphoma"]

protocolSection.statusModule.lastUpdatePostDateStruct.date

"2026-02-20"

protocolSection.identificationModule.nctId

"NCT07055477"

protocolSection.identificationModule.officialTitle

"A Phase I Trial of Anti-CC Chemokine Receptor 4 Chimeric Antigen Receptor T Cells (CCR4 CAR T Cells) for CCR4 Expressing T-cell Malignancies Including Peripheral T-cell Non-Hodgkin Lymphoma (PTCL) and Cutaneous T-cell Non-Hodgkin Lymphoma (CTCL)"

protocolSection.statusModule.overallStatus

"RECRUITING"

protocolSection.designModule.phases

["PHASE1"]

protocolSection.statusModule.resultsFirstPostDateStruct.date

""

Study condition terms

• Relapsed and/or Refractory Mature T Cell Malignancy (protocolSection.conditionsModule.conditions)
• Peripheral T-Cell Lymphoma (protocolSection.conditionsModule.conditions)
• Angioimmunoblastic T-cell Lymphoma (protocolSection.conditionsModule.conditions)
• Anaplastic Large Cell Lymphoma (protocolSection.conditionsModule.conditions)
• Hepatosplenic T-cell Lymphoma (protocolSection.conditionsModule.conditions)
• Monomorphic Epithelialtropic Intestinal Lymphoma (protocolSection.conditionsModule.conditions)
• Enteropathy Associated T-cell Lymphoma (protocolSection.conditionsModule.conditions)
• Cutaneous T-Cell Lymphoma (protocolSection.conditionsModule.conditions)
• Mycosis Fungoides (protocolSection.conditionsModule.conditions)
• Subacute Panniculitis-like T-cell Lymphoma (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.